Pharma Journalist -

GlycoMimetics unveiled design for a randomized, double blind, placebo-controlled Phase 3 Clinical Trial to evaluate GMI-1271 in combination with MEC (Mitoxantrone, etoposide and Ara-C)…
Read More...

Sagent Pharmaceuticals asserted the voluntary nationwide recall of ten lots of Methylprednisolone Sodium Succinate for Injection, USP, 40mg, 125mg, and 1g. The products were…
Read More...

Sinovac Biotech which is a provider of bio-pharmaceutical products in China has plans to accentuate the corporate governance and management of Sinovac Biotech Co., Ltd, the main…
Read More...

Biopharmaceutical company, Moleac that is focused on research and development of new medicines for central nervous system (CNS) diseases and injuries, today announced that the U.S. Food…
Read More...

Prometic Life sciences asserted that the U.S Food and Drug Adminstration has granted a Rare Pediatric Disease Designation to its Inter-Alpha-Inhibitor-Proteins for the treatment of…
Read More...

Vanda Pharmaceuticals asserted that HETLIOZ which is a circadian regulator exhibited significant and clinically meaningful benefits in symptoms of jet lag disorder. Jet lag disorder…
Read More...

MyBiotics Pharma which is a microbiome therapeutics company announced that it has entered into second option agreement with Ferring Holding Ltd. for the validation of MyBiotics'…
Read More...

Benitec Biopharma which is a biotechnology company developing innovative therapeutics based on a combination of gene therapy and its patented gene-silencing technology named ddRNAi…
Read More...

Trovagene which is a precision medicine biotechnology company developing targeted cancer therapeutics asserted that the initial patient successfully completed first cycle 1 Treatment in…
Read More...

In a bid to enhance and streamline data management processes for Aequus- sponsored clinical trials studying specific Cannabinoid-rich formulations for treating a number of neurological…
Read More...